Azathioprine

Results: 117



#Item
61Microsoft Word - ~[removed]doc

Microsoft Word - ~[removed]doc

Add to Reading List

Source URL: www.tritonpharma.ca

Language: English - Date: 2011-11-08 15:24:38
62Report on Carcinogens, Thirteenth Edition For Table of Contents, see home page:  http://ntp.niehs.nih.gov/go/roc13 Azathioprine CAS No[removed]

Report on Carcinogens, Thirteenth Edition For Table of Contents, see home page:  http://ntp.niehs.nih.gov/go/roc13 Azathioprine CAS No[removed]

Add to Reading List

Source URL: ntp.niehs.nih.gov

Language: English - Date: 2014-10-02 09:28:03
    63300 Northfield Road Bedford, OH[removed]Telephone: ([removed]or[removed] MATERIAL SAFETY DATA SHEET

    300 Northfield Road Bedford, OH[removed]Telephone: ([removed]or[removed] MATERIAL SAFETY DATA SHEET

    Add to Reading List

    Source URL: www.bedfordlabs.com

    Language: English - Date: 2014-07-22 11:10:41
    64Pregnancy and Immunosuppressives Cyclophosphamide and methotrexate are unsafe for use during pregnancy. The safety of mycophenolate mofetil during pregnancy is unknown. Azathioprine is unsafe for use during pregnancy bec

    Pregnancy and Immunosuppressives Cyclophosphamide and methotrexate are unsafe for use during pregnancy. The safety of mycophenolate mofetil during pregnancy is unknown. Azathioprine is unsafe for use during pregnancy bec

    Add to Reading List

    Source URL: www.lsnflorida.org

    Language: English - Date: 2013-04-27 09:29:10
    65Pregnancy and Immunosuppressives Cyclophosphamide and methotrexate are unsafe for use during pregnancy. The safety of mycophenolate mofetil during pregnancy is unknown. Azathioprine is unsafe for use during pregnancy bec

    Pregnancy and Immunosuppressives Cyclophosphamide and methotrexate are unsafe for use during pregnancy. The safety of mycophenolate mofetil during pregnancy is unknown. Azathioprine is unsafe for use during pregnancy bec

    Add to Reading List

    Source URL: www.thelupussupportnetwork.org

    Language: English - Date: 2013-04-27 09:29:10
    66ACR SABLE Patient Recruitment Poster_HR PRINT_no number.pdf

    ACR SABLE Patient Recruitment Poster_HR PRINT_no number.pdf

    Add to Reading List

    Source URL: www.lupusresearch.org

    Language: English - Date: 2013-10-25 12:31:15
    67Microsoft Word - 021083s006lbl.doc

    Microsoft Word - 021083s006lbl.doc

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2009-03-31 16:03:43
    68Subspecialty Group Letter - Differentiating Drugs Covered Under Medicare Part B

    Subspecialty Group Letter - Differentiating Drugs Covered Under Medicare Part B

    Add to Reading List

    Source URL: www.health.ny.gov

    Language: English - Date: 2007-11-09 15:19:04
    69Health Canada Endorsed Important Safety Information on IMURAN® and PURINETHOL® March 26, 2014 Dear Health Care Professional, Subject:

    Health Canada Endorsed Important Safety Information on IMURAN® and PURINETHOL® March 26, 2014 Dear Health Care Professional, Subject:

    Add to Reading List

    Source URL: www.tritonpharma.ca

    Language: English - Date: 2014-03-26 12:02:51
    70Patients at high-immunologic risk  Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily maintenance doses of 5 mg (

    Patients at high-immunologic risk  Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily maintenance doses of 5 mg (

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2010-02-04 16:31:08